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Abstract
Background: Migraine is a recurrent headache disease related to genetic variants. The brain-derived neurotrophic
factor (BDNF) gene rs6265 (Val66Met) and rs2049046 polymorphism has been found to be associated with migraine.
However, their roles in this disorder are not well established. Then we conduct this meta-analysis to address this issue.
Methods: PubMed, Web of Science and Cochrane databases were systematically searched to identify all relevant
studies. Odds ratio (OR) with corresponding 95% confidence interval (CI) was used to estimate the strength of
association between BDNF gene rs6265 and rs2049046 polymorphism and migraine.
Results: Four studies with 1598 cases and 1585 controls, fulfilling the inclusion criteria were included in our
meta-analysis. Overall data showed significant association between rs6265 polymorphism and migraine in allele model
(OR = 0.86, 95%CI: 0.76–0.99, p = 0.03), recessive model (OR = 0.84, 95%CI: 0.72–0.98, p = 0.03) and additive model (GG vs
GA: OR = 0.85, 95%CI: 0.72–1.00, p = 0.04), respectively. We also found significant association between rs2049046(A/T)
polymorphism and migraine in allele model (OR = 0.88, 95%CI: 0.79–0.98, p = 0.02), recessive model (OR = 0.80, 95%CI:
0.67–0.96, p = 0.02) and additive model (AA vs TT: OR = 0.72, 95%CI: 0.57–0.92, p = 0.008; AA vs AT: OR = 0.81, 95%CI: 0.
67–0.99, p = 0.03), respectively.
Conclusion: Our meta-analysis suggested that BDNF rs6265 and rs2049046 polymorphism were associated with
common migraine in Caucasian population. Further studies are awaited to update this finding in Asian population and
other types of migraine.
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Background
Migraine, characterized by recurrent headaches accom-
panying autonomic symptoms, is the 6th leading cause of
global years lived with disability (YLDs) according to the
Global Burden of Disease Study 2013 [1]. The patho-
logical mechanisms of migraine are very complex. Existing
evidences have revealed its association with central
sensitization, cortical spreading depression, trigeminovas-
cular system activation and neurogenic inflammation.
Brain-derived neurotrophic factor (BDNF) is the most
abundant neurotrophin in the brain [2, 3]. Previous
study has recognized it as an important modulator of
central and peripheral nociceptive pathways [4, 5]. It
distributes in both spinal and supra-spinal levels, con-
tributing to central sensitization [6]. Also it is co-
expressed with Calcitonin gene-related peptide (CGRP),
an important molecule of migraine, in the trigeminal
ganglion neurons [7]. Moreover, significant increase of
serum BDNF level was detected in migraine attack
patients [8]. Therefore, the alteration in BDNF metabol-
ism may be contribute to the mechanism of migraine.
The Val66Met (rs6265) polymorphism is the most
common and studied variant of BDNF gene. It can
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disrupt the release of mature BNDF and contribute to
migraine. Meanwhile, the rs2049046 polymorphism was
also found to be associated with migraine. It may influence
the transcription of BDNF gene to induce migraine [9, 10].
The association between BDNF gene variant and
migraine attracts more and more attention in recent
years. However, their roles among the disorder sufferers
are still not well established [9–12]. Then we systematic-




The literature search was performed in October 2016
without restriction of language, region and publication
type. PubMed, Web of Science and Cochrane databases
were systematically searched to identify all relevant stud-
ies. The following terms and their combinations were
searched in title and/or abstract: BDNF, brain-derived
neurotrophic factor, polymorphism, migraine and head-
ache. The reference lists of included studies and review
articles were manually searched to find relevant studies.
The search was conducted independently by two of the
authors (Cai and Shi). If the same group of participants
was studied for more than one times, the latest publica-
tion was included.
Inclusion and exclusion criteria
Studies investigating the association between BNDF
polymorphism and migraine were evaluated. The follow-
ing inclusion criteria were applied to select eligible stud-
ies: (1) independent case–control study evaluated the
association between BDNF polymorphism and migraine;
(2) BDNF rs6265 (G/A) polymorphism and/or rs2049046
(A/T) polymorphism were evaluated; (3) migraine
diagnosis should met the International Headache
Society (IHS) criteria; (4) Hardy-Weinberg equilibrium
(HWE) must be performed; (5) genotype data of cases
and controls must be available. Exclusion criteria were
as follows: (1) no controls; (2) reviews, comments and
animal studies.
Data extraction and quality assessment
Data from included studies was extracted and summa-
rized independently by two of the authors (Cai and Shi).
Any disagreement was resolved by discussion and reex-
amination. The following information was extracted pro-
spectively: first author, publish year, country, ethnicity,
age, sex, number of cases and controls, frequency of
available genotype, genotype method and Hardy-
Weinberg equilibrium (HWE) evidence in controls.
The quality of included studies was evaluated inde-
pendently through the Newcastle-Ottawa scale (NOS) by
two of the authors (Cai and Shi). NOS is composed of
eight assessment items for quality appraisal, with score
ranging from 0–9 [13]. According to the NOS scores,
the included studies were classified as low-quality study
(0–4), moderate-quality study (5–6) and high-quality
study (7–9). Any disagreement was resolved by the
senior authors (Fang and Zhang).
Statistical analysis
The strength of the association between BDNF genetic
polymorphism and migraine was calculated using odds
ratio (OR), with corresponding 95% confidence interval
(CI). BDNF rs6265 (G/A) polymorphism and rs2049046
(A/T) polymorphism were evaluated separately in the al-
lele model, dominant model, recessive model and addi-
tive model. Heterogeneity among studies was examined
through Chi squared-based Q-test and I2 test [14, 15].
The heterogeneity difference was regarded significant
when p < 0.1 in Q test or I2 > 50%. If there was
heterogeneity among studies, random-effects model
(DerSimonian Laird method) was applied to calculate
the summary OR, otherwise, the fixed-effects model
(Mantel-Haenszel method) was used [16]. The Z-test
was used to assess the significance of pooled OR, and
p < 0.05 was considered significant.
One-way sensitivity analysis was performed to evaluate
the influence of a single study on the overall result.
Begg’s test and Egger’s test were applied to assess publi-
cation bias [17, 18]. All p values were two tailed. All of
the meta-analysis were conducted using STATA 12.0
(StataCorp, College Station, TX, USA).
Results
A total of 89 studies were identified through searching
in PubMed, Web of Science and Cochrane databases.
Four studies with 1598 cases and 1585 controls fulfilling
the predefined inclusion criteria were included in the
current meta-analysis (Fig. 1). Among them, agreement
between two reviewers was 98% for study selection and
95% for quality assessment of studies.
Characteristics of eligible studies
The characteristics of included studies were shown in
Table 1. The genotype and allele frequency of included
studies were shown in Table 2. All the included cases
were from five Caucasian population groups, two of
which came from the Australian-based independent co-
horts [10]. The five groups received BDNF rs6265 (G/A)
polymorphism analysis, and four of them got rs2049046
(A/T) polymorphism assessment. All SNPs of included
studies were in Hardy-Weinberg equilibrium (HWE).
The NOS score of the studies were no less than 6, show-
ing good quality. The frequency of rs6265 G allele in
BDNF gene was about 80%, which was consistent with
previous finding [19].
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Meta-analysis between BNDF gene polymorphism and
migraine
BDNF rs6265 (G/A) polymorphism in migraine
The main results and heterogeneity between rs6265 (G/
A) polymorphism and migraine were shown in Tables 3
and 4. The fixed-effects model was used for all analysis,
for their heterogeneity were not significant.
The overall data showed significant association be-
tween rs6265 polymorphism and migraine in allele
model (OR = 0.86, 95%CI: 0.76–0.99, p = 0.03), recessive
model (OR = 0.84, 95%CI: 0.72–0.98, p = 0.03) and
additive model (GG vs GA: OR = 0.85, 95%CI: 0.72–1.00,
p = 0.04). The association was not significant in domin-
ant model (OR = 0.85, 95%CI: 0.56–1.28, p = 0.42) or
additive model (GG vs AA: OR = 0.81, 95%CI: 0.53–1.22,
p = 0.31) (Table 4 and Fig. 2).
BDNF rs2049046 (A/T) polymorphism in migraine
The results and heterogeneity between rs2049046 (A/T)
polymorphism and migraine were in Tables 3 and 4.
Heterogeneity differences were not significant among all
the studies. And the fixed-effects model was used.
The data indicated significant association between
rs2049046 (A/T) polymorphism and migraine in allele
model (OR = 0.88, 95%CI: 0.79–0.98, p = 0.02), recessive
model (OR = 0.80, 95%CI: 0.67–0.96, p = 0.02) and addi-
tive model (AA vs TT: OR = 0.72, 95%CI: 0.57–0.92, p =
0.008; AA vs AT: OR = 0.81, 95%CI: 0.67–0.99, p = 0.03).
No significant association was revealed in dominant
model (OR = 0.89, 95%CI: 0.75–1.06, p = 0.18) (Table 4
and Fig. 3).
Sensitivity analysis and publication bias
In the sensitivity analysis, there was no change of statis-
tical significance in our analysis when any single study
was omitted. Both Begg’s test and Egger’s test indicated
that there was no publication bias in our meta-analysis
(P > 0.05).
Discussion
This meta-analysis evaluated the association between
BDNF gene polymorphism and migraine and showed
that BNDF rs6265 (G/A) and rs2049046 (A/T) poly-
morphism were associated with migraine in Caucasian
population.
BDNF, which is associated with the pathogenesis of
migraine, shares a wide distribution in central nervous
system, such as hippocampus, amygdala, and hypothal-
amus. It can modulate synaptic plasticity, neurogenesis,
neural growth and differentiation [3]. This molecule is
synthesized by tyrosine kinase A-positive sensory neu-
rons and acts through TrkB receptors in the nociceptive
pathways [20, 21]. Genetic study discovered that BDNF
gene is composed of 11 exons that are alternatively
spliced to encode different transcripts [22]. Previous
studies found that central BDNF can cause neuroplas-
ticity and interact with molecules related to migraine
[7, 23]. Serum and cerebrospinal fluid BDNF level
Fig. 1 Flow diagram of literature search and study selection
Table 1 Main characteristics of all eligible studies
First author Year Country Ethnicity Eligible participants (M/F) Age, mean (SD), years Genotype
method
SNPa HWE NOS
Cases Controls Cases Controls
Salih et al. 2016 Turkey Caucasian 288 (137/151) 288 (133/155) 31.26 (10.28) 31.53 (8.92) RT-PCR 1,2 yes 6
Heidi et al. 2014 Australia Caucasian 277 277 - - PCR-RFLP 1,2 yes 7
Heidi et al. 2014 Australian Caucasian 580 580 - - PCR-RFLP 1,2 yes 7
Carolina et al. 2010 Portugal Caucasian 188 (35/153) 287 (70/217) 36.14 (12.84) 36.42 (12.35) RT-PCR 1,2 yes 7
Martin et al. 2008 German Caucasian 265 (43/222) 153 (43/110) 43.6 (13) 64.5 (9.4) RT-PCR 1 yes 7
Abbreviation: M male, F female, SNP single-nucleotide polymorphism, HWE Hardy-Weinberg equilibrium, NOS Newcastle-Ottawa scale, PCR-RELP polymerase chain
reaction-restricted fragments length polymorphism, RT-PCR real-time polymerase chain reaction
a1 = rs6265; 2 = rs2049046
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elevated in patient with migraine attack. Meanwhile,
platelets BDNF level decreased in this sufferers [24, 25].
These findings indicate that alteration of BDNF was
responsible for migraine.
The rs6265 polymorphism is a G to A single nucleo-
tide polymorphism (SNP) of BDNF gene at nucleotide
196. It is located in the 5’ pro-protein region of BDNF,
resulting in the replacement of the Val66 in the pro-
BDNF sequence with a Met. Previous eQTL (expression
quantitative trait locus) study has confirmed the associ-
ation between BDNF Val66Met variant and mRNA level
in whole peripheral blood in European [26, 27]. Subjects
with Val66 displayed a significantly higher BDNF mRNA
expression level compared with subjects with Met66
variant. Also, Met BDNF form cannot be sorted from
Golgi to appropriated secretory granules, consequently
impairing the secretion function of BDNF [28]. Thus the
rs6265 polymorphism can modify the level of BDNF
mRNA and the intracellular packaging of pro-BDNF, to
finally affect the secretion of mature protein. And the
change of BDNF level and neurotrophic-induced neural
plasticity could affect the trigeminal pain-related evoked
responses and cortical pain processing [29]. Several stud-
ies have evaluated the role of rs6265 polymorphism in
migraine. However, the intrinsic effects were not thor-
oughly demonstrated. In this analysis, we confirm this
supposition that rs6265 polymorphism may be associ-
ated with migraine. The associations between rs6265
Table 2 Distribution of genotype and allele of BDNF polymorphism between cases and controls
rs number Source Group N Genotypes (N,freq) Alleles (N,freq)
rs6265(G/A) GG GA AA G A
Salih et al. cases 288 196 (68.1%) 84 (29.2%) 8 (2.8%) 476 (82.6%) 100 (17.4%)
controls 288 217 (75.3%) 66 (22.9%) 5 (1.7%) 500 (86.8%) 76 (13.2%)
Heidi et al. cases 201 131 (65.2%) 64 (31.8%) 6 (3.0%) 326 (81.1%) 76 (18.9%)
controls 246 171 (69.5%) 68 (27.6%) 7 (2.8%) 410 (83.3%) 82 (16.7%)
Heidi et al. cases 411 265 (64.5%) 129 (31.4%) 17 (4.1%) 659 (80.2%) 163 (19.8%)
controls 546 373 (68.3%) 156 (28.6%) 17 (3.1%) 902 (82.6%) 190 (17.4%)
Carolina et al. cases 188 118 (62.8%) 64 (34.0%) 6 (3.2%) 300 (79.8%) 76 (20.2%)
controls 287 183 (63.8%) 95 (33.1%) 9 (3.1%) 461 (80.3%) 113 (19.7%)
Martin et al. cases 265 148 (55.9%) 104 (39.2%) 13 (4.9%) 400 (75.5%) 130 (24.5%)
controls 153 88 (57.5%) 57 (37.3%) 8 (5.2%) 233 (76.1%) 73 (23.9%)
Meta-analysis cases 1353 858 (63.4%) 445 (32.9%) 50 (3.7%) 2161 (79.9%) 545 (20.1%)
controls 1520 1032 (67.9%) 442 (29.1%) 46 (4.5%) 2506 (82.4%) 534 (17.6%)
rs2049046(A/T) AA AT TT A T
Salih et al. cases 288 64 (22.2%) 147 (51.0%) 77 (26.7%) 275 (47.7%) 301 (52.3%)
controls 288 82 (28.5%) 128 (44.4%) 78 (27.1%) 292 (50.7%) 284 (49.3%)
Heidi et al. cases 235 46 (19.6%) 115 (48.9%) 74 (31.5%) 207 (44.0%) 263 (56.0%)
controls 244 60 (24.6%) 128 (52.5%) 56 (23.0%) 248 (50.8%) 240 (49.2%)
Heidi et al. cases 549 111 (20.2%) 279 (50.8%) 159 (29.0%) 501 (45.6%) 597 (54.4%)
controls 561 135 (24.1%) 280 (49.9%) 146 (26.0%) 550 (49.0%) 572 (51.0%)
Carolina et al. cases 188 51 (27.1%) 99 (52.7%) 38 (20.2%) 201 (53.5%) 175 (46.5%)
controls 287 79 (27.5%) 143 (49.8%) 65 (22.6%) 301 (52.4%) 273 (47.6%)
Meta-analysis cases 1260 272 (21.6%) 640 (50.8%) 348 (27.6%) 1184 (47.0%) 1336 (53.0%)
controls 1380 356 (25.8%) 679 (49.2%) 345 (25.0%) 1391 (50.4%) 1369 (49.6%)
Abbreviation: BDNF brain-derived neurotrophic factor
Table 3 Heterogeneity among included studies with Chi squared-based Q-test and I2 test










p I2 p I2 p I2 p I2 p I2
rs6265(G/A) 5 0.72 0% 0.94 0% 0.78 0% 0.92 0% 0.84 0%
rs2049046(A/T) 4 0.41 0% 0.24 29% 0.72 0% 0.40 0% 0.76 0%
Abbreviation: W wild allele, M mutant allele, WW wild homozygote, WM heterozygote, MM mutant homozygote
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polymorphism and this disease in allele, recessive and
additive models were all in borderline significant.
Consistent with our results, Salih et al.[12] found a bor-
derline significant difference of rs6265 polymorphism in
migraine patients, demonstrating a positive correlation
between BDNF rs6265 polymorphism and migraine. Di
Lorenzo C et al. found that rs6265 polymorphism was
associated with monthly drug consumption in medication
overuse headache patients, indicating its role in mi-
graine chronicity [30]. Moreover, we found this posi-
tive association though enlarging the sample size by
combining similar studies. So previous studies with
negative results may be due to insufficient sample
sizes [9–11].
The rs2049046 polymorphism is located at 5’ end of
the BDNF gene, upstream to a region that contains
Table 4 Meta-analysis of the association between BDNF rs6265 and rs2049046 polymorphism and migraine










OR (95% CI) p OR (95% CI) p OR (95% CI) p OR (95% CI) p OR (95% CI) p
rs6265(G/A) 5 0.86 (0.76, 0.99) 0.03 0.85 (0.56, 1.28) 0.42 0.84 (0.72, 0.98) 0.03 0.81 (0.53, 1.22) 0.31 0.85 (0.72, 1.00) 0.04
rs2049046(A/T) 4 0.88 (0.79, 0.98) 0.02 0.89 (0.75, 1.06) 0.18 0.80 (0.67, 0.96) 0.02 0.78 (0.62, 0.97) 0.02 0.81 (0.67, 0.99) 0.03
Abbreviation: W wild allele, M mutant allele, WW wild homozygote, WM heterozygote, MM mutant homozygote
Fig. 2 Forest plot of the association between BDNF rs6265 polymorphism and migraine in the allele, recessive and additive model. Abbreviation:
BDNF, brain-derived neurotrophic factor
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obesity-associated SNPs [31]. It may influence the
tissue-specific transcription or levels of BDNF, thus
regulating migraine [32]. In the present study, we re-
vealed that individuals carrying rs2049046 T allele might
be more susceptive to develop migraine. This finding is
consistent with two other studies conducted by Sutherland
et al. and Lemos et al. [9, 10]. However, the potential
role of rs2049046 polymorphism in the process of
BDNF formation and secretion required further in-
vestigation. Basic studies on the biological functions
of rs2049046 polymorphism and its correlation with
migraine are needed.
The studies included were all moderate-high quality,
providing a reliable basis for the current analysis. No
relative case–control studies were excluded from our
analysis. No evidence of public bias was detected in our
Fig. 3 Forest plot of the association between BDNF rs2049046 polymorphism and migraine in the allele, recessive and additive model.
Abbreviation: BDNF, brain-derived neurotrophic factor
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meta-analysis and the heterogeneity between different
studies was insignificant. However, the number of stud-
ies included in our meta-analysis was limited. Mean-
while, all the cases were from Caucasian population, and
the G allele frequency of BDNF gene rs6265 polymorph-
ism was found to be different between Caucasian (80%)
and Asian (56%) population, making our results be un-
appropriated for Asian countries [19]. Future studies are
awaited to update our finding in Asian population. Due
to the limited available studies and data, we did not sub-
group the patients based on migraine with or without
aura. Besides, in our analysis we only evaluated middle-
age migraine patients with or with aura, limiting our re-
sults to be applied for children with migraine and other
types of migraine, such as chronic migraine. Whether
the expression of BDNF rs6265 and rs2049046 poly-
morphism has any difference in different migraine types
remains to unclear. In our analysis, we did not obtain
raw SNPs data of each study. It limited our further ex-
ploration of the combined effect of this two SNPs, which
required further study.
So far, several Genome-Wide Association Studies
(GWAS) have been perform to evaluate the susceptibility
loci of migraine [33–37]. However, the polymorphism of
BDNF gene did not reach the significance in them. This
difference didn’t indicate the impact of BDNF gene poly-
morphism was negligible. It may due to the large penal-
ties on significance thresholds in GWAS model (p of
association ≤ 10−7), leading to the lack of statistical
power of BDNF gene. As a candidate-gene association
study, our hypothesis arose from the positive association
between BDNF and migraine revealed in previous clin-
ical researches. This connection strengthened the reli-
ability of our results. Up to now, with large sample sizes
used to analysis, only a small number of susceptible
genes has been found to be associated with migraine
[38]. Thus candidate-gene association study is still an
effective and direct way to illustrate the association
between gene and disease.
Conclusion
In conclusion, our meta-analysis suggested that BDNF
rs6265 and rs2049046 polymorphism were associated with
common migraine in Caucasian population. And it re-
quires further studies to evaluate the association of BDNF
rs6265 and rs2049046 polymorphism with migraine in
Asian population and other types of migraine.
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